Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004023442 | SCV004906206 | uncertain significance | Cardiovascular phenotype | 2023-09-22 | criteria provided, single submitter | clinical testing | The c.13196A>C (p.K4399T) alteration is located in exon 29 (coding exon 29) of the APOB gene. This alteration results from a A to C substitution at nucleotide position 13196, causing the lysine (K) at amino acid position 4399 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, |
RCV000508865 | SCV000605941 | pathogenic | Hypercholesterolemia, familial, 1 | no assertion criteria provided | research |